UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation

Leukemia & lymphoma, 2014-02, Vol.55 (2), p.314-319

2014

Volltextzugriff (PDF)

Low‐dose fludarabine and cyclophosphamide combined with rituximab in the first‐line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long‐term results of project Q‐lite by the Czech CLL Study Group

British journal of haematology, 2021-05, Vol.193 (4), p.769-778

2021

Volltextzugriff (PDF)

Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks

Scientific reports, 2021-01, Vol.11 (1), p.322-322, Article 322

2021

Volltextzugriff (PDF)

High CXCR3 on Leukemic Cells Distinguishes IgHVmut from IgHVunmut in Chronic Lymphocytic Leukemia: Evidence from CD5high and CD5low Clones

Journal of immunology research, 2020-01, Vol.2020

2020

Volltextzugriff (PDF)

Granulocyte transfusions collected after steroid priming for severe infections during neutropenia: A single center experience

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2019-11, Vol.26 (4), p.299-303

2019

Volltextzugriff (PDF)

Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2020-12, Vol.164 (4), p.425-434

2020

Volltextzugriff (PDF)

Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015

Klinická onkologie, 2015-10, Vol.28 Suppl 3 (Suppl 3), p.3S22-3S29

2015

Volltextzugriff (PDF)

Markedly eccentric peripheral vascular stenoses: percutaneous atherectomy with an endomyocardial biopsy device

Radiology, 2000-11, Vol.217 (2), p.587

2000

Volltextzugriff (PDF)

Single-Agent Ibrutinib Versus Real-World (RW) Treatments for Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Adjusted Comparison of Resonate-2™ with the Cllear and Lyon-Sud Rw Databases

Blood, 2021-11, Vol.138 (Supplement 1), p.4679-4679

2021

Volltextzugriff (PDF)

Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects

Oncotarget, 2017-10, Vol.8 (49), p.84889-84901

2017

Volltextzugriff (PDF)

Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks

Leukemia research, 2019-04, Vol.79, p.60-68

2019

Volltextzugriff (PDF)

Operational cures after interferon-alpha in patients with chronic myeloid leukemia in Central and Northern Moravia

Journal of interferon & cytokine research, 2012-05, Vol.32 (5), p.230

2012

Volltextzugriff (PDF)

Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years

Leukemia research, 2019-10, Vol.85, p.106218-106218, Article 106218

2019

Volltextzugriff (PDF)

High CXCR3 on Leukemic Cells Distinguishes [IgHV.sup.mut] from [IgHV.sup.unmut] in Chronic Lymphocytic Leukemia: Evidence from [CD5.sup.high] and [CD5.sup.low] Clones

Journal of Immunology Research, 2020-06, Vol.2020

2020

Volltextzugriff (PDF)

High CXCR3 on Leukemic Cells Distinguishes IgHV mut from IgHV unmut in Chronic Lymphocytic Leukemia: Evidence from CD5 high and CD5 low Clones

Journal of immunology research, 2020-06, Vol.2020, p.1-10

2020

Volltextzugriff (PDF)

Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia

Leukemia research, 2018-09, Vol.72, p.113-119

2018

Volltextzugriff (PDF)

Gender, Age and TP53 Aberrations in Context of Complex Karyotypes in Chronic Lymphocytic Leukemia Patients in the Era of Chemo +/- Immunotherapy

Blood, 2017-12, Vol.130, p.2991-2991

2017

Volltextzugriff (PDF)

Carotid stenting in patients at high risk for endarterectomy

Cor et vasa (English ed.), 2010-12, Vol.52 (Suppl.), p.59-64

2010

Volltextzugriff (PDF)

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

Annals of hematology, 2019-12, Vol.98 (12), p.2749-2760

2019

Volltextzugriff (PDF)

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases

Blood, 2017-12, Vol.130, p.5342-5342

2017

Volltextzugriff (PDF)

High CXCR3 on Leukemic Cells Distinguishes IgHV mut from IgHV unmut in Chronic Lymphocytic Leukemia: Evidence from CD5high and CD5low Clones

Journal of immunology research, 2020-01, Vol.2020, p.7084268-7084268

2020

Volltextzugriff (PDF)

3.4 Benefits and Limits of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography in Patients with CLL and Small Lymphocytic Lymphoma

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S198-S199

2011

Volltextzugriff (PDF)

Varieties of Lettuce Forming Distinct Microbial Communities Inhabiting Roots and Rhizospheres with Various Responses to Osmotic Stress

Horticulturae, 2022-12, Vol.8 (12), p.1174

2022

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)

Sprache

Englisch
(37)
Tschechisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(17)
Chronic Lymphocytic Leukemia
(12)
Humans
(11)
Hematology
(9)
Middle Aged
(8)
Oncology
(8)
Aged
(7)
Female
(7)
Male
(7)
Leukemia
(6)
Adult
(5)
Patients
(4)
Aged, 80 And Over
(3)
Flow Cytometry
(3)
Ibrutinib
(3)
Immunology
(3)
Leukemia, Lymphocytic, Chronic, B-Cell - Diagnosis
(3)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(3)
Leukemia, Lymphocytic, Chronic, B-Cell - Mortality
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real‐world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)

Real‐world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO‐CLLEAR Study by the Czech CLL Study Group

2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation

Low‐dose fludarabine and cyclophosphamide combined with rituximab in the first‐line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long‐term results of project Q‐lite by the Czech CLL Study Group

Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks

High CXCR3 on Leukemic Cells Distinguishes IgHVmut from IgHVunmut in Chronic Lymphocytic Leukemia: Evidence from CD5high and CD5low Clones

Granulocyte transfusions collected after steroid priming for severe infections during neutropenia: A single center experience

Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study

Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015

Markedly eccentric peripheral vascular stenoses: percutaneous atherectomy with an endomyocardial biopsy device

Single-Agent Ibrutinib Versus Real-World (RW) Treatments for Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Adjusted Comparison of Resonate-2™ with the Cllear and Lyon-Sud Rw Databases

Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects

Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks

Operational cures after interferon-alpha in patients with chronic myeloid leukemia in Central and Northern Moravia

Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years

High CXCR3 on Leukemic Cells Distinguishes [IgHV.sup.mut] from [IgHV.sup.unmut] in Chronic Lymphocytic Leukemia: Evidence from [CD5.sup.high] and [CD5.sup.low] Clones

High CXCR3 on Leukemic Cells Distinguishes IgHV mut from IgHV unmut in Chronic Lymphocytic Leukemia: Evidence from CD5 high and CD5 low Clones

Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia

Gender, Age and TP53 Aberrations in Context of Complex Karyotypes in Chronic Lymphocytic Leukemia Patients in the Era of Chemo +/- Immunotherapy

Carotid stenting in patients at high risk for endarterectomy

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases

High CXCR3 on Leukemic Cells Distinguishes IgHV mut from IgHV unmut in Chronic Lymphocytic Leukemia: Evidence from CD5high and CD5low Clones

3.4 Benefits and Limits of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography in Patients with CLL and Small Lymphocytic Lymphoma

Varieties of Lettuce Forming Distinct Microbial Communities Inhabiting Roots and Rhizospheres with Various Responses to Osmotic Stress

Suchergebnisse filtern